Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Innoviva Inc (INVA)
NASDAQ:INVA
Innoviva (INVA) Stock Price & Analysis
255 Followers
INVA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$10.64 - $15.67
Previous Close$13.17
Volume1.43M
Average Volume (3M)704.71K
Market Cap
$862.69M
Enterprise Value$1.16B
Total Cash (Recent Filing)$144.05M
Total Debt (Recent Filing)$444.69M
Price to Earnings (P/E)5.8
Beta0.19
Next Earnings
Jul 26, 2023EPS Estimate
$0.26Last Dividend Ex-Date
Sep 08, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)2.25
Shares Outstanding65,504,384
10 Day Avg. Volume670,086
30 Day Avg. Volume704,712
Standard Deviation0.10
R-Squared0.09
Alpha-0.00188
Financial Highlights & Ratios
Price to Book (P/B)3.09
Price to Sales (P/S)11.30
Price to Cash Flow (P/CF)24.80
P/FCF Ratio16.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.66
Enterprise Value/Gross Profit3.57
Enterprise Value/Ebitda3.66
Forecast
1Y Price Target
$22.50Price Target Upside70.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Innoviva News
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INVA FAQ
What was Innoviva Inc’s price range in the past 12 months?
Innoviva Inc lowest stock price was $10.64 and its highest was $15.67 in the past 12 months.
What is Innoviva Inc’s market cap?
Currently, no data Available
When is Innoviva Inc’s upcoming earnings report date?
Innoviva Inc’s upcoming earnings report date is Jul 26, 2023 which is in 50 days.
How were Innoviva Inc’s earnings last quarter?
Innoviva Inc released its earnings results on May 09, 2023. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.19.
Is Innoviva Inc overvalued?
According to Wall Street analysts Innoviva Inc’s price is currently Undervalued.
Does Innoviva Inc pay dividends?
Innoviva Inc pays a Semiannually dividend of $0.25 which represents an annual dividend yield of N/A. See more information on Innoviva Inc dividends here
What is Innoviva Inc’s EPS estimate?
Innoviva Inc’s EPS estimate is $0.26.
How many shares outstanding does Innoviva Inc have?
Innoviva Inc has 65,504,390 shares outstanding.
What happened to Innoviva Inc’s price movement after its last earnings report?
Innoviva Inc reported an EPS of $0.42 in its last earnings report, beating expectations of $0.23. Following the earnings report the stock price went up 5.536%.
Which hedge fund is a major shareholder of Innoviva Inc?
Among the largest hedge funds holding Innoviva Inc’s share is Woodline Partners LP. It holds Innoviva Inc’s shares valued at 6M.
---
Innoviva Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$22.50 (70.45% Upside)
$22.50 (70.45% Upside)
Blogger Sentiment
Bullish
INVA Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 411.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $7.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.24%
12-Months-Change
Fundamentals
Return on Equity
49.15%
Trailing 12-Months
Asset Growth
2.01%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Innoviva Inc
Innoviva, Inc. is engaged in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.
---
Top 5 ETFs holding INVA
Vanguard Total Stock Market ETF
$22.60M
Vanguard Health Care ETF
$2.55M
iShares U.S. Pharmaceuticals ETF
$1.22M
iShares Core S&P Total U.S. Stock Market ETF
$1.11M
Schwab U.S. Broad Market ETF
$454.83K
Up to five ETFs with an Outperform Smart Score that hold INVA. The ETFs are listed according to market value of INVA within the ETF
---
Aclaris Therapeutics
―
Pliant Therapeutics
―
Amneal Pharmaceuticals
―
Belite Bio, Inc. ADR
―
---